FICHe eHealth Accelerator Enters Final Phase with 20 Companies

FICHeThe FICHe eHealth accelerator has announced the 20 companies that will enter the third and final phase of the program. The final phase will be a 7-month mentorship period and each company will receive up to € 152.000 in working capital.

Timo Haikonen, chairman of the evaluation committee: "It has been most gratifying to monitor and witness the enthusiasm, innovation and dedication of the FICHe finalists. Every one of them deserves a credit for their hard work. May success follow them all."

Michel van Schaik, member of the evaluation committee adds: "The overall quality of all the participants was very good. Seeing all these innovations brought to the health sector in one place, proofs there is a lot of potential out there."

Paul Pelsmaeker, founder of the European FICHe accelerator: "We are all very excited about the outcome of the evaluation. All twenty selected companies have great potential in the market and that drives the FICHe team and coaches to help them grow in the next 7 months."

The companies selected for the final phase of FICHe are:

  • Px Healthcare (Netherlands), patient experience optimizing oncology outcomes;
  • Panatomy (Germany), online smart imaging database;
  • NeticTECH (Poland), medVC, remote video/audio consultation tool;
  • Medbravo (Spain), finding treatment options based on clinical trial for cancer patients;
  • Clinical Graphics (Netherlands), cloud based service for detection of osteoarthritis;
  • Andiamo (United Kingdom), 3D body scans collaboration cloud platform;
  • Psico Smart Apps (Spain), virtual environments for the treatment of anxiety disorders;
  • Scyfer (Netherlands), deep learning platform to detect degenerative brain disease in 3D-MRI;
  • Betawerk (Netherlands), IncoSense Smart, smart care service that measures incontinence;
  • Tripmedic (Malta), multi-sided platform to match-make international patients to doctors;
  • Mind Myths (Ireland); online mindfulness platform;
  • OurPath (United Kingdom), 12-week online lifestyle programme to prevent T2D;
  • Oviva (Switzerland), remote personal dietitian platform;
  • PLUX (Portugal), biofeedback modules for Ara platform;
  • Inbiolab (Netherlands). hARMONIC, miniaturized respiratory monitor based on EMG;
  • Ideable Solutions (Spain), Kwido, multi-device platform for the care of people;
  • NeuroAtHome (Spain), gamified software platform to deliver physical and cognitive therapy;
  • HealthApp (Spain), mobile application for the treatment of eating disorders;
  • Umanick (Spain), biometric platform for patient identification with HIS/EMR integration;
  • MySphera (Spain), tools to offer full transparency of healthcare processes in hospitals.

The twenty companies will be mentored and coached through an intense 7-month period led by the three ecosystems (Amsterdam, Murcia and Oulu) that are part of the project consortium.

The FICHe accelerator program will conclude with a demo day in 2016 where all companies will present to investors.

Related news articles:

About FICHe
FICHe provides companies with the overall funding of EUR 6.24 million for developing eHealth applications and creating sustainable business models. Funding will be distributed through a three-step process. In the first stage, companies will receive 15 000 euro for business model development. In the next phase, 40 out of the 80 companies will receive 50 000 euro for proof-of-concept. The third phase entering 20 out of the 40 companies will receive additionally 152 000 euro for working prototype development. At best, companies are therefore offered up to 217 000 euros funding.

FICHe is co-funded under the European Union's Programme for research, technological development and demonstration. Project partners are University of Oulu, Business Oulu, TIC BioMed, FFIS de la region de Murcia, TNO, Amsterdam Economic Board, Stichting zorgInc., Dutch eHealth Fund Management BV and Stichting Digitalezorg.nl.

About FIWARE technology
FIWARE is an innovative, open cloud-based infrastructure for cost-effective creation and delivery of Future Internet applications and services, at a scale not seen before. FIWARE API specifications are public and royalty-free, driven by the development of an open source reference implementation which accelerates the availability of commercial products and services based on FIWARE technologies.

Most Popular Now

Merck and Tencent Announce Collaboration…

Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public...

Merck Granted U.S. Patent for Novel Comb…

Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates...

The European Health Catapult Program for…

Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their...

Applications Now Open for Pioneering Dig…

The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, announces that applications for the 2019 Propel@YH digital health accelerator programme are now open. Propel@YH has been...

Flagship Axe the Fax Trust Rolls out Hyb…

Leeds Teaching Hospitals NHS Trust (LTHT), the organisation at the forefront of the national Axe the Fax campaign, is implementing an electronic fax solution to tackle its last remaining machines...

First EU Citizens Using ePrescriptions i…

The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a...

Boehringer Ingelheim (Canada) Ltd. and I…

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology...

Final Report: Provision of a Market Stud…

The aim of the study is to examine the telemedicine market in Europe and to understand the factors that determine its development. The analysis maps telemedicine applications and solutions, and...

Open Access Drug Development Tools Featu…

New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of...

The NHS Long Term Plan: Cracking the Da …

Opinion Article by Prof. Michael Thick, Chief Medical Officer, Chief Clinical Information Officer, IMS MAXIMS Reading the NHS Long Term Plan this week, I had a definite sense of déjà vu...

Big Data Approach Shown to be Effective …

Researchers at Rensselaer Polytechnic Institute who developed a blood test to help diagnose autism spectrum disorder have now successfully applied their distinctive big data-based approach to evaluating possible treatments. The...

Highland Marketing Advisory Board Respon…

The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment...